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Cigarette smoking is known to contribute to many dis-
eases, including cancer, chronic obstructive pulmonary
disease, stroke, cardiovascular disease and peptic
ulcers [1–5]. Investigators have attempted to elucidate
the mechanisms of the pathogenesis associated with
cigarette smoking, but the conclusions were not con-
sistent. A basic hypothesis is that free radicals cause
oxidative damage to macromolecules such as lipids,
proteins and DNA; therefore, free radicals are believed
to be instrumental in the pathogenesis of diseases [6,7].
In accordance with this theory, antioxidants such as
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The relationship between cigarette smoking and cell damage is complicated, particularly consid-
ering the role of oxidative stress. The aim of this study was to identify the relationships among
plasma nicotine metabolites, lipophilic antioxidants, and metabolic parameters in smokers and non-
smokers. This cross-sectional study recruited 100 subjects who visited the Department of Family
Medicine at Kaohsiung Medical University Hospital. Excluding 14 ineligible cases, 46 smokers
and 40 non-smokers were enrolled. Plasma nicotine metabolites, lipophilic antioxidants (including
retinol, lycopene, α-carotene, β-carotene, δ-tocopherol, γ-tocopherol and α-tocopherol), related
metabolic parameters, and body composition (including height, weight, body mass index, body
fat, and waist circumference) were examined by comparison of means, correlations and regres-
sions. Significant correlations among nicotine metabolites, age, sex, body composition and plasma
lipophilic antioxidants were noted. Nicotine metabolites, age, body height and body weight were
closely associated with plasma antioxidant levels (p < 0.05) in multiple linear regression. The levels
of α-carotene, β-carotene, γ-tocopherol and lycopene were lower in smokers than in non-smokers
(p < 0.01). The plasma level of high-sensitivity C-reactive protein (hsCRP), which is a marker for
high cardiovascular risk, was higher in smokers than in non-smokers (p = 0.003). We conclude that
the lower plasma antioxidant levels and the higher level of hsCRP in smokers may lead to decreased
protective efficacy compared with non-smokers. Further studies are warranted to support our
hypothesis.
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carotenes are believed to play important roles in
resisting damage from oxidative stress resulting from
cigarette smoking. Although the inferences to date
regarding the relationship between smoking and
antioxidants are equivocal, differences in the effects of
antioxidants between smokers and non-smokers have
been studied [8–13]. For instance, Alberg demon-
strated that the circulating concentrations of ascorbic
acid, α-carotene, β-carotene, and cryptoxanthin are, on
average, 25% lower in smokers compared with non-
smokers [8]. A study by Mezzetti et al showed that
plasma vitamin C and lipid peroxide levels were lower
and higher, respectively, in smokers than in non-
smokers when these subjects were undergoing coro-
nary bypass surgery [13]. However, there is still limited
information regarding the relationship between ciga-
rette smoking and plasma antioxidant concentrations
in disease-free individuals.
Nicotine is the main substance that results in addic-
tion to smoking. Because nicotine is a substance spe-
cific to cigarette smoking, it can be used as a marker
for how many cigarettes are consumed by the smoker.
Therefore, it allows us to quantify the amount that a
subject smokes. Nicotine metabolites, including coti-
nine, nicotine-N-oxide and a number of derivatives,
offer a priority consideration. These are more accurate
than other biomarkers such as carboxyhemoglobin 
or carbon monoxide, which are do not predictor the
amount smoked. In addition, such biomarkers may be
present as a result of exposure to other environmental
factors [14].
Cigarette smoking is related to cardiovascular dis-
eases. Elevated levels of high-sensitivity C-reactive
protein (hsCRP) or homocysteine appear to indicate
risk for cardiovascular diseases [15–18]. Even though
the associations between cardiovascular disease and
hsCRP and homocysteine are well known, very few
studies have assessed the association between cigarette
smoking and hsCRP and homocysteine levels. Two
studies have demonstrated that hsCRP levels were
higher in smokers than in non-smokers [19,20], while
another two studies have reported that there was no
significant association between hsCRP and smoking
status itself and that there was no difference in hsCRP
levels between smokers and non-smokers [21,22]. In
studies that assessed the relationship between homo-
cysteine levels and cigarette smoking, some investiga-
tors suggested that the plasma homocysteine level is
higher in smokers than in non-smokers [22–24], while
others demonstrated the opposite [25]. Therefore, the
research indicates that the associations between hsCRP
and cigarette smoking and between homocysteine and
cigarette smoking may be complicated.
Therefore, the aim of this study was to determine
the differences in body composition, metabolic char-
acteristics, and levels of hsCRP, homocysteine and
plasma lipophilic antioxidants between smoking and
non-smoking subjects.
METHODS
This cross-sectional study was approved by the
Institutional Review Board of Kaohsiung Medical
University Hospital. One hundred subjects who visited
the Department of Family Medicine at Kaohsiung
Medical University Hospital were recruited initially.
The smoking subjects were selected from people who
visited for smoking-cessation consultations in 2002
and 2003. Non-smokers were selected to match the
age of the smoking participants. Our exclusion criteria
included the following: subjects with any identified
disease (e.g. diabetes, hypertension and coronary
artery disease); those already under nicotine replace-
ment therapy; those regularly taking vitamin sup-
plements; vegetarians; and those taking medicine.
Excluding 14 ineligible individuals, a total of 86 par-
ticipants (16–78 years old), including 46 smokers and
40 non-smokers, were enrolled.
Participants were asked to record their regular
dietary habits before blood sample collection. Parti-
cipants were blinded as to which blood examination
was performed to reduce the possibility of deliberate
food intake. Fasting blood samples were drawn in
the morning and were stored immediately in an ice
chest and kept out of sunlight. At the same time,
demographic data were collected via questionnaires, 
and body composition was measured by well-trained
examiners employing a bioelectric impedance analy-
sis meter [26,27]. Heparinized blood samples were
centrifuged at 3,000 revolutions per minute for 10
minutes at 4°C within 1 hour of being drawn. Plasma
was separated and stored in aliquots at −80°C until re-
quired for analysis. During transportation, the plasma
aliquots were stored at –20°C, which was maintained
by dry ice. Blood analysis included plasma nicotine
metabolites, metabolic parameters (blood sugar, cho-
lesterol, triglyceride, glutamate pyruvate transaminase
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[GPT], creatinine, uric acid [UA], hsCRP and homo-
cysteine), and antioxidants (α-carotene, β-carotene, 
δ-tocopherol, γ-tocopherol, α-tocopherol, retinol and
lycopene).
Samples were thawed and mixed well before analy-
sis. Antioxidants were analyzed by high-pressure 
liquid chromatography [28–30]. Aliquots of plasma
were mixed with ethanol and hexane. The sample was
then centrifuged at 10,000 revolutions per minute for
5 minutes and the hexane layer was collected and
evaporated under nitrogen, and finally dissolved in a
mobile phase in the high-pressure liquid chromatog-
raphy system. The mobile phase consisted of a solvent
system of 68:22:7 (v/v/v) acetonitrile-tetrahydrofuran-
methanol with 1% (v/v) ammonium acetate. The sep-
aration module (Waters 2695; Waters Corp., Milford,
MA, USA) was equipped with a Waters Novapak C18
column (150 × 3.9 mm) and two programmable multi-
wavelength detectors (Dual λ Absorbance Detector
and Scanning Fluorescence Detector; both from Waters
Corp.). The detection wavelength was set at 295 nm
for tocopherols, 325 nm for retinol and 450 nm for
carotenoids. The column was fitted with a pre-column
module (Guard-Pak Pre-column; Waters Corp.) and
all samples were pre-filtered through a 0.45-μm filter
(Waters Corp.). The analysis procedure used in this
study was modified from a previously reported pro-
tocol [31]. Plasma nicotine metabolites were measured
by a competitive chemiluminescent immunoassay
method using IMMULITE 1000 [32], which can detect
plasma nicotine metabolites at the same time, which
corresponds to the amount of nicotine absorbed in vivo.
Homocysteine and hsCRP were also measured by a
competitive chemiluminescent immunoassay [33,34].
Cholesterol, triglyceride, blood sugar (AC sugar), cre-
atinine, GPT, and UA were detected by a nephelometric
method using the Beckman Coulter LX-20 (Beckman
Coulter Inc., Fullerton, CA, USA).
SPSS version 14.0 (SPSS Inc., Chicago, IL, USA) for
Windows was used for statistical analysis. Descrip-
tive analyses were examined to identify differences
in demographic characteristics, metabolic parameters
and plasma antioxidant levels between smokers and
non-smokers. Correlation coefficients and multiple
linear regression were used to identify associations
among plasma nicotine metabolites, age, sex, body
composition and plasma antioxidants.
RESULTS
Demographic and metabolic characteristics
of the participants
Age, sex, smoking duration, and body composition
(height, weight, body mass index [BMI], waist cir-
cumference and body fat) are summarized in Table 1.
Antioxidant variations by smoking status
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Table 1. Comparison of demographic characteristics and metabolic parameters between smokers and non-smokers
Smokers (n = 46) Non-smokers (n = 40) p
Demographic characteristics
Age (yr) 33.5 ± 15.6 40.7 ± 18.6 0.184*
Male/female (n) 37/9 22/18 0.020†‡
Smoking (yr) 14.1 ± 11.9 0 < 0.001*§
Height (cm) 170.5 ± 5.3 161.9 ± 6.9 0.088*
Weight (kg) 69.1 ± 16.2 63.2 ± 12.0 0.499*
BMI (kg/m2) 23.7 ± 4.8 24.1 ± 4.5 0.622*
Body fat (%) 24.1 ± 3.3 28.9 ± 10.4 < 0.001*§
Waist circumference (inches) 29.5 ± 5.2 30.3 ± 5.4 0.697*
Metabolic characteristics
Cholesterol (mg/dL) 183.8 ± 24.2 186.1 ± 32.3 0.072*
Triglyceride (mg/dL) 118.5 ± 37.8 126.3 ± 36.1 0.311*
Blood sugar (mg/dL) 99.3 ± 23.5 109.2 ± 34.6 0.254*
Creatinine (mg/dL) 0.71 ± 0.26 0.77 ± 0.31 0.588*
Glutamate pyruvate transaminase (IU/L) 25.0 ± 16.7 26.2 ± 10.9 0.036*‡
Uric acid (mg/dL) 5.1 ± 1.2 4.9 ± 1.2 0.794*
Nicotine metabolites (ng/mL) 339.0 ± 194.4 0 < 0.001*§
High-sensitivity C-reactive protein (mg/dL) 0.64 ± 1.20 0.18 ± 0.35 0.003*§
Homocysteine (μmol/L) 10.1 ± 2.1 9.3 ± 2.4 0.117*
*t test; †χ2 test; ‡p < 0.05; §p < 0.01.
There were no statistically significant differences
between the two groups in terms of age, height,
weight, BMI or waist circumference. However, there
was a difference in body fat between the two groups
(p < 0.001). The body fat percentage of smokers
(mean = 24.1%) was significantly lower than for non-
smokers (mean = 28.9%). Metabolic parameters of
participants are also displayed in Table 1. There were
no statistically significant differences between the two
groups in terms of cholesterol, triglyceride, blood
sugar, creatinine, UA and homocysteine. HsCRP was
higher in smokers (mean = 0.64 mg/dL) than in non-
smokers (mean = 0.18 mg/dL) (p = 0.003).
Relationships among plasma nicotine
metabolites, body compositions and
plasma antioxidant levels
Comparisons of plasma antioxidant levels between
smokers and non-smokers are shown in Table 2. There
were statistically significant differences between the
two groups in terms of α-carotene, β-carotene, γ-toco-
pherol and lycopene levels. The plasma α-carotene
(smokers vs. non-smokers, mean = 3.3 μg/dL vs.
6.7 μg/dL, p < 0.001), β-carotene, γ-tocopherol and
lycopene levels (all p < 0.01) were lower in smokers
than in non-smokers.
We performed correlation analysis to identify cor-
relations among nicotine metabolites, age, sex, body
composition and antioxidant levels, and the results are
shown in Table 3. Nicotine metabolites were inversely
related to α-carotene, β-carotene, α-tocopherol, δ-toco-
pherol, γ-tocopherol and lycopene levels. With regard
to age, correlations were evident between age and 
α-carotene, β-carotene, α-tocopherol and retinol levels
(p < 0.01).
Table 4 shows the relationships among dependent
variables (α-carotene, β-carotene, α-tocopherol and
retinol) and independent factors such as age, body
height, body weight, and nicotine metabolite levels
by multiple linear regression. Age was positively cor-
related with α-carotene, β-carotene, α-tocopherol and
retinol levels. Nicotine metabolites were negatively
correlated with β-carotene and α-tocopherol levels.
DISCUSSION
Our study demonstrated that plasma antioxidant lev-
els (lycopene, α-carotene, β-carotene and γ-tocopherol)
were significantly lower in smokers than in non-
smokers. Our results are consistent with these of 
a previous study, which compared the antioxidant 
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Table 2. Comparison of plasma antioxidant levels between smokers and non-smokers, as analyzed by t test
Smokers (n = 46) Non-smokers (n = 40) p
α-carotene (μg/dL) 3.3 ± 1.2 6.7 ± 4.0 < 0.001*
β-carotene (μg/dL) 11.7 ± 6.7 34.9 ± 22.8 < 0.001*
γ-tocopherol (μg/mL) 1.2 ± 0.4 1.4 ± 0.7 < 0.001*
Lycopene (μg/dL) 4.3 ± 1.7 6.3 ± 3.8 0.002*
δ-tocopherol (μg/mL) 0.085 ± 0.030 0.100 ± 0.046 0.106
α-tocopherol (μg/mL) 7.6 ± 2.5 9.6 ± 3.2 0.172
Retinol (μg/dL) 49.3 ± 11.7 47.8 ± 14.5 0.236
*p < 0.01.
Table 3. Relationships (Pearson’s correlation coefficients) between plasma levels of antioxidants and nicotine metabo-
lites, age and body composition
α-carotene β-carotene α-tocopherol δ-tocopherol γ-tocopherol Retinol Lycopene
Nicotine metabolites −0.472* −0.501* −0.367* −0.279* −0.321* −0.061 −0.262†
Age 0.388* 0.485* 0.657* −0.079 −0.104 0.402* 0.128
Height −0.420* −0.532* −0.138 0.010 −0.113 0.185 −0.108
Weight −0.220† −0.329* 0.179 0.126 0.071 0.279* 0.055
BMI −0.049 −0.130 0.235† 0.139 0.130 0.229† 0.101
Body fat 0.168 0.046 0.034 0.118 0.178 −0.044 0.172
Waist circumference 0.091 0.017 0.340* 0.063 0.049 0.308* 0.122
*p < 0.01; †p < 0.05. BMI = body mass index.
levels according to smoking exposure [9]. They sug-
gested that subjects exposed to smoking had lower
plasma β-carotene levels than those who were not.
However, Dietrich et al’s study demonstrated that
the γ-tocopherol level was higher in smokers than in
non-smokers [9], which contrasts with our study. In
the study done by Wei et al, smokers had significantly
lower plasma levels of α-carotene and β-carotene,
whereas the reduction in tocopherol and lycopene
levels in smokers was very limited [35]. Chronic ciga-
rette smokers have lower concentrations of many
dietary antioxidants (β- and α-carotene) in serum and
buccal mucosa cells compared with nonsmokers, an
effect which is not entirely ascribable to diet [11].
There is no doubt that the levels of β- and α-carotene
were lower in smokers compared with non-smokers.
However, the findings of higher and lower levels of
γ-tocopherol in smokers are still contentious. The stud-
ies of Gabriel et al [11] and Dietrich et al [9] revealed
that γ-tocopherol was higher in smokers than in non-
smokers. However, we found the opposite. Similarly,
Wei et al’s study [35] also demonstrated that the
reduction of tocopherol was very limited. However,
no clear mechanism for the relationship between the
amount of γ-tocopherol and smoking status has been
described in the literature. Therefore, further studies
are needed to clarify this finding.
Plasma antioxidant levels were closely, but
inversely related to levels of plasma nicotine metabo-
lites in our study. We propose the explanation that
more regular cigarette smoking would markedly
affect plasma nicotine metabolites and thus decrease
plasma antioxidant levels. Furthermore, our finding
suggests that plasma nicotine metabolites are appro-
priate as biomarkers for smoking consumption. These
biomarkers should be applicable use in future stud-
ies of cigarette smoking.
The associations between hsCRP and cigarette
smoking were inconclusive in the previous studies
[19–24]. Our finding that the hsCRP levels were sig-
nificantly higher in smokers than in non-smokers
indicates that cigarette smoking causes greater burden
in terms of vascular diseases mediated by elevated
hsCRP.
The relationship between cigarette smoking and
body weight change is also controversial in the litera-
ture. Our clinical experience suggested that subjects
who smoked would have a lower body weight. This
study found that the body fat of smokers (24.1 ± 3.3%)
was lower than that of non-smokers (28.9 ± 10.4%)
(p < 0.001). A statistical linear relationship between
plasma nicotine metabolites and body fat was also
found (data not shown). However, the differences
between the two groups in terms of body weight, BMI
Antioxidant variations by smoking status
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Table 4. Multiple linear regression models of relationships among dependent variables (plasma antioxidant levels)
and independent factors
Models; factors B (SE) 95% CI p
Dependent variable: α-carotene
Age 0.058 (0.019) 0.021 to 0.094 0.003
Height −0.153 (0.043) −0.239 to −0.067 0.001
Adjusted R2 = 24.4%
Dependent variable: β-carotene
Nicotine metabolites −0.036 (0.007) −0.050 to −0.021 < 0.001
Age 0.473 (0.092) 0.291 to 0.656 < 0.001
Weight −0.416 (0.107) −0.630 to −0.203 < 0.001
Adjusted R2 = 48.0%
Dependent variable: α-tocopherol
Nicotine metabolites −0.003 (0.001) −0.005 to −0.001 0.003
Age 0.104 (0.014) 0.077 to 0.131 < 0.001
Adjusted R2 = 47.7%
Dependent variable: retinol
Age 0.299 (0.072) 0.155 to 0.442 < 0.001
Weight 0.243 (0.086) 0.073 to 0.414 0.006
Adjusted R2 = 21.7%
SE = standard error; CI = confidence interval.
and waist circumference were not clear. A previous
study demonstrated that average cigarette smokers
have a lower BMI than non-smokers [36]. The small
sample size in this study probably limited reaching
an equivocal outcome. Further studies with a larger
sample size are needed to clarify this hypothesis.
An interesting outcome of this study was that age
was positively related to levels of plasma antioxidants
including α-carotene, β-carotene, α-tocopherol and
retinol. This can be explained in three ways: (1) people
with older age have healthier lifestyles, meaning that
their nutrition is more balanced than younger people;
(2) the use of and need for antioxidants in younger
people are greater than in older people; (3) lipophilic
antioxidants can accumulate in the body by aging;
therefore they can be detected more frequently in
older people than in younger people.
A notable feature of our study is that we did not
restrict the diet of the study subjects because diet
control per se would change the dietary habits of the
individuals. Individuals may have a different need and
capacity for nutrient consumption. If we restrict the
diet of our study subjects, we may alter the balance in
antioxidant levels. Nevertheless, we recognize that
the cross-sectional study design is a weakness because
of the presence of potential confounding factors. On
the other hand, our careful and comprehensive sur-
veys of the participants, particularly the rigorous and
comprehensive laboratory examinations, are strengths
of this study.
In this study, the levels of antioxidants (including
α-carotene, β-carotene, γ-tocopherol and lycopene)
were lower in smokers than in non-smokers. The level
of hsCRP was higher in smokers than in non-smokers.
Levels of nicotine metabolites were inversely associ-
ated with plasma levels of lipophilic antioxidants.
Therefore, cigarette smoking may influence oxidative
stress by affecting the levels of plasma antioxidants,
which may be involved in the mechanisms underlying
various diseases. Our study is the first attempt to
determine the relationship among cigarette smoking,
plasma antioxidants, plasma nicotine metabolites and
body composition in healthy subjects in Taiwan.
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吸菸者和非吸菸者在血漿中抗氧化劑濃度的差異
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吸菸和細胞傷害之間的關聯性是很複雜的，其中氧化壓力也被認為有關聯。本研究的
目的在研究血漿中尼古丁代謝物、脂溶性抗氧化劑、生化代謝指標、以及吸菸的相關
性。這個橫斷式研究將 100 位在高雄醫學大學家庭醫學科看診的個案納入研究。排除
掉不符合收案條件的 14 位個案，46 位吸菸者和 40 位非吸菸者完成收案。測量的項
目包括：血漿尼古丁代謝物、脂溶性抗氧化劑 (包括維他命 A、蕃茄紅素、α-胡蘿蔔
素、β-胡蘿蔔素、δ-維生素 E、γ-維生素 E 和 α-維生素 E)、代謝性生化指標，
和生體結構組成 (包括身高、體重、身體質量指數、體脂肪、以及腰圍 )。統計方法包
括平均數比較、相關係數分析、以及回歸檢定。血漿尼古丁代謝物、年齡、性別、生
體結構組成、和血漿脂溶性抗氧化劑濃度呈現統計顯著的相關性。複回歸分析則顯
示：血漿尼古丁代謝物、年齡、身高和體重，是主要影響血漿抗氧化劑濃度的因素 (p 
< 0.05)。吸菸者血漿中 α-胡蘿蔔素，β-胡蘿蔔素，γ-維生素 E 和蕃茄紅素的量
低於非吸菸者 (p < 0.01)。與心血管危險性相關的生物指標：血漿中高敏感性 C-反應
蛋白 (hsCRP) 在吸菸者的濃度比非吸菸者高。我們認為這些現象解釋了：吸菸者因
為血漿中較低的抗氧化物濃度及較高的 hsCRP 濃度可能會造成較低的細胞保護效
果。需要進一步的研究來支持我們的假說。
關鍵詞：抗氧化劑，吸菸，尼古丁代謝物
(高雄醫誌 2009;25:423–30)
